Clinical Trial Update: Use of Flozins (Empagliflozin/Dapagliflozin) for Prevention of AKI

View source ↗

Summary

A clinical trial in recruitment evaluating FLOZINS (empagliflozin and dapagliflozin) to prevent acute kidney injury in patients with coronary artery disease, in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Acute Kidney Injury
• Coronary Artery Disease
• Kidney Injury

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Empagliflozin (empagliflozin)

Snippet

Sponsor: Collegium Medicum w Bydgoszczy | Conditions: Coronary Artery Disease, Acute Kidney Injury | Status: RECRUITING